Results 171 to 180 of about 26,149 (232)

Anti-JNK2 peptide–siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice [PDF]

, 2018
Akk, Antonina, Bacon, John, Hou, Kirk K, Miller, Mark J, Palekar, Rohun U, Pan, Hua, Pham, Christine T.N, Schlesinger, Paul H, Springer, Luke E, Wickline, Samuel A, Yan, Huimin, Yang, Lihua   +11 more
core   +1 more source

Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant. [PDF]

Am J Transplant, 2018
Cheng Q, Patel K, Lei B, Rucker L, Allen DP, Zhu P, Vasu C, Martins PN, Goddard M, Nadig SN, Atkinson C.   +10 more
europepmc   +1 more source

Complement C3a receptor antagonism for ME/CFS neuroinflammation

Complement component 3a receptor (C3AR1) is activated by elevated C3a levels in ME/CFS patients, triggering microglial activation and neuroinflammation in brain regions controlling fatigue and cognitive function. C3AR1 antagonists like SB290157 or PMX205 could reduce complement-mediated neuroinflammation and improve central nervous system symptoms.
openaire   +1 more source

C/EBP-β-regulated complement hyperactivation in spleen of SFTSV-infected mice: A clue to targeted complement therapy. [PDF]

PLoS Pathog
Liu Y, Xu M, Huang X, Liu X, Fan K, Zhang Y, Xing C, Tang H, Jiang J, Xu K, He M, Xu G, Zhang C.   +12 more
europepmc   +1 more source

Effects of protease inhibitors in experimental septic shock [PDF]

, 1992
Fink, Edwin, Hoffmann, H., Siebeck, Matthias, Spannagl, Michael   +3 more
core  

Targeting the C3 signaling axis of the complement system: immune microenvironment regulation and emerging therapeutic strategies for glioblastoma. [PDF]

Front Immunol
Huang J, Wang Q, Chen J.
europepmc   +1 more source

The Complement System in the Setting of Critical Illness-A Narrative Review. [PDF]

Biomolecules
Ampelakiotou K, Nikitopoulou I, Kokkoris S, Kotanidou A, Dimopoulou I, Detsika MG.   +5 more
europepmc   +1 more source

The Role of Complement Anaphylatoxins (C3a and C5a) in Non-small Cell Lung Cancer: A Systematic Review. [PDF]

Cureus
Skarentzos K, Karagialani DK, Mitros V, Economopoulou P, Foukas P.   +4 more
europepmc   +1 more source

Complement and inflammasome crosstalk in chronic inflammation. [PDF]

Front Immunol
Janžič L, Kouter K.
europepmc   +1 more source

Complement system in cancer: friend or foe of immunotherapy. [PDF]

J Immunother Cancer
Shah HK, Prem S, Wu X, Liszewski MK, Atkinson JP, Singh AK, Kapoor V.   +6 more
europepmc   +1 more source